Close Menu

NEW YORK (GenomeWeb) – Biocept announced today that it has signed agreements to sell $9.3 million in stock and warrants to certain institutional investors.

According to the company, it will sell about 4.3 million shares of its common stock at $2.15 per share, as well as warrants to purchase up to roughly 2.2 million shares of common stock at an exercise price of $2.50 a share. The warrants are exercisable six months after the close of the transaction and expire five years from the date they become exercisable.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sep
30
Sponsored by
LGC SeraCare Life Sciences

Non-invasive prenatal testing (NIPT) continues to expand globally to support maternal-fetal patient care. 

Oct
09
Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.